학술논문

Efficacy and safety of MYL-1501D vs insulin glargine in patients with type 1 diabetes after 52 weeks: Results of the INSTRIDE 1 phase III study
Document Type
Article
Source
In: Diabetes, Obesity and Metabolism. (Diabetes, Obesity and Metabolism, August 2018, 20(8):1944-1950)
Subject
Language
English
ISSN
14631326
14628902